BMC Pharmacology and Toxicology, a new BMC series journal
Today two of our pharmacology titles within the BMC series, BMC Pharmacology and BMC Clinical Pharmacology, are joining forces to form BMC Pharmacology and Toxicology. Our aim is to facilitate connections between pre-clinical and clinical research, especially in this era of translational medicine. The new journal has an expanded scope to incorporate the interdisciplinary field of toxicology. You can read more about our aims in this Editorial.
“I think the merger is an excellent idea, especially since the borders between pharmacology, clinical pharmacology and toxicology can be rather ‘blurry’ and because of clinical and translational sciences being a major effort in the US and elsewhere.”
Paul Insel, University of California, Editorial Board Member.
Ironically, the subject matter …

